28-Mar-2024
Bitcoin Vs. Gold Vs. SPY: Which Asset Class Would've Given Best Returns On $1000 Investment In Q1?
Benzinga (Fri, 29-Mar 2:24 AM ET)
Here's How Much You Would Have Made Owning Eli Lilly and Co Stock In The Last 5 Years
Benzinga (Thu, 28-Mar 10:30 AM ET)
CVS, Elevance Health to cover Novo Nordisk’s Wegovy: WSJ
Seeking Alpha News (Thu, 28-Mar 10:00 AM ET)
Sen. Sanders goes after Novo Nordisk on study on Ozempic low manufacture cost
Seeking Alpha News (Wed, 27-Mar 5:02 PM ET)
Eli Lilly & Co (LLY) Receives a Buy from Truist Financial
TipRanks (Wed, 27-Mar 8:36 AM ET)
Altimmune falls after Q4 results; obesity drug data released
Seeking Alpha News (Wed, 27-Mar 8:26 AM ET)
Viking (NASDAQ:VKTX): Positive Trial Data Boosts Stock
TipRanks (Wed, 27-Mar 2:06 AM ET)
Amazon reportedly leaning on weight loss frenzy to boost pharmacy unit
Seeking Alpha News (Tue, 26-Mar 2:15 PM ET)
Cytokinetics gains amid renewed takeover speculation
Seeking Alpha News (Tue, 26-Mar 2:01 PM ET)
Biotech Roundtable: Is CRISPR all its cracked up to be?
Seeking Alpha News (Tue, 26-Mar 11:43 AM ET)
Eli Lilly is a drug firm with a focus on neuroscience, cardiometabolic, cancer, and immunology. Lilly's key products include Verzenio for cancer; Mounjaro, Zepbound, Jardiance, Trulicity, Humalog, and Humulin for diabetes; and Taltz and Olumiant for immunology.
Eli Lilly And Company trades on the NYSE stock market under the symbol LLY.
As of March 28, 2024, LLY stock price declined to $777.96 with 2,894,277 million shares trading.
LLY has a beta of 0.19, meaning it tends to be less sensitive to market movements. LLY has a correlation of 0.01 to the broad based SPY ETF.
LLY has a market cap of $738.50 billion. This is considered a Mega Cap stock.
Last quarter Eli Lilly And Company reported $9 billion in Revenue and $2.49 earnings per share. This beat revenue expectation by $423 million and exceeded earnings estimates by $.30.
In the last 3 years, LLY stock traded as high as $800.78 and as low as $178.58.
The top ETF exchange traded funds that LLY belongs to (by Net Assets): VTI, VOO, SPY, IVV, VUG.
LLY has outperformed the market in the last year with a price return of +133.9% while the SPY ETF gained +33.6%. LLY has also outperformed the stock market ETF in the last 3 month and 2 week periods returning +34.0% and +2.7%, respectively, while the SPY returned +10.1% and +1.7%, respectively.
LLY support price is $764.86 and resistance is $791.50 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that LLY stock will trade within this expected range on the day.